Clinical trial
Early Detection Biomarkers for Mesothelioma Among Asbestos and Vermiculite Exposed Populations
NCT00897247 is registered in ClinicalTrials.gov with Barbara Ann Karmanos Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Detection Biomarkers for Mesothelioma Among Asbestos and Vermiculite Exposed Populations
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- October 31, 2013
- Enrollment
- 494 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malignant mesothelioma, pulmonary complications